FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 65 filers reported holding FORTRESS BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,464 | -32.9% | 44,480 | 0.0% | 0.00% | – |
| Q1 2023 | $36,474 | +25.2% | 44,480 | 0.0% | 0.00% | – |
| Q4 2022 | $29,134 | -23.3% | 44,480 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | +18.8% | 44,480 | +17.6% | 0.00% | – |
| Q2 2022 | $32,000 | -37.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -46.3% | 37,814 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -22.1% | 37,814 | 0.0% | 0.00% | – |
| Q3 2021 | $122,000 | -9.6% | 37,814 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | +1.5% | 37,814 | 0.0% | 0.00% | – |
| Q1 2021 | $133,000 | +10.8% | 37,814 | 0.0% | 0.00% | – |
| Q4 2020 | $120,000 | -35.8% | 37,814 | -18.3% | 0.00% | – |
| Q3 2020 | $187,000 | +85.1% | 46,272 | +22.4% | 0.00% | – |
| Q2 2020 | $101,000 | +42.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2020 | $71,000 | – | 37,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |